Formula 1 Cognitive Compound for Neuronal Transmission and Memory Loss
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective treatments to improve memory, cognition function, and learning function, as these functions decline with age and are affected by brain atrophy, shrinkage, and neurological disorders.
Innovation Solution
Administering a therapeutically effective amount of a compound of Formula 1 or its pharmaceutically acceptable salt, which enhances neuronal transmission, improves scopolamine-induced cognitive impairment, ameliorates cognitive deficits, and increases long-term potentiation, thereby improving memory, cognition, and learning functions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for cognitive decline, then some symptomatic relief may be achieved, but the underlying neuronal transmission deficits and long-term potentiation impairment remain unresolved
Solution Approach 1:
The compound of Formula 1 is designed to simultaneously address multiple cognitive deficits through a single agent. It enhances neuronal transmission, improves scopolamine-induced cognitive impairment, ameliorates NMDA receptor hypofunction, and increases long-term potentiation, making it a multi-functional treatment for various aspects of cognitive decline
2Reliability
If brain atrophy and shrinkage progress with age, then neurological function naturally declines, but effective interventions to reverse or significantly improve this decline are lacking
Solution Approach 1:
The compound acts preemptively to enhance neuronal transmission and increase long-term potentiation before severe cognitive decline sets in. By strengthening synaptic connections and neuronal communication early, it prevents or delays the progression of age-related cognitive impairment and brain atrophy
Data Source
AI summary
The present invention relates to methods of improving memory function, cognition function, and learning function by administering a compound of Formula I to a subject in need thereof. The invention further relates to methods of delaying or slowing the loss of memory function, cognition function, and learning function by administering a compound of Formula 1 to a subject in need thereof.


